Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 504

1.

Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.

Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE.

Am J Dermatopathol. 2001 Jun;23(3):185-9.

PMID:
11391097
2.
3.

Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.

Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota J, Sarlomo-Rikala M.

Am J Surg Pathol. 2001 Feb;25(2):205-11.

PMID:
11176069
4.

Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.

Dorvault CC, Weilbaecher KN, Yee H, Fisher DE, Chiriboga LA, Xu Y, Chhieng DC.

Cancer. 2001 Oct 25;93(5):337-43.

PMID:
11668469
5.

Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors.

King R, Googe PB, Weilbaecher KN, Mihm MC Jr, Fisher DE.

Am J Surg Pathol. 2001 Jan;25(1):51-7.

PMID:
11145251
6.

Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.

Xu X, Chu AY, Pasha TL, Elder DE, Zhang PJ.

Am J Surg Pathol. 2002 Jan;26(1):82-7.

PMID:
11756773
7.

Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation.

Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE.

Mod Pathol. 2001 Jan;14(1):6-9.

8.

Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma.

Granter SR, Weilbaecher KN, Quigley C, Fisher DE.

Appl Immunohistochem Mol Morphol. 2002 Mar;10(1):47-51.

PMID:
11893035
11.

Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.

Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ.

Am J Surg Pathol. 2001 Jun;25(6):782-7.

PMID:
11395556
12.
13.

p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.

Kanik AB, Yaar M, Bhawan J.

J Cutan Pathol. 1996 Jun;23(3):205-10.

PMID:
8793654
14.

Immunohistochemical characteristics of melanoma.

Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW.

J Cutan Pathol. 2008 May;35(5):433-44. doi: 10.1111/j.1600-0560.2007.00891.x. Review.

PMID:
18399807
15.

Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors.

Chang KL, Folpe AL.

Adv Anat Pathol. 2001 Sep;8(5):273-5. Review.

PMID:
11556535
17.

Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.

King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE.

Am J Pathol. 1999 Sep;155(3):731-8.

18.

Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.

Sheffield MV, Yee H, Dorvault CC, Weilbaecher KN, Eltoum IA, Siegal GP, Fisher DE, Chhieng DC.

Am J Clin Pathol. 2002 Dec;118(6):930-6.

PMID:
12472287
19.

Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.

Kucher C, Zhang PJ, Pasha T, Elenitsas R, Wu H, Ming ME, Elder DE, Xu X.

Am J Dermatopathol. 2004 Dec;26(6):452-7.

PMID:
15618925
20.

KBA.62: a useful marker for primary and metastatic melanomas.

Pag├Ęs C, Rochaix P, al Saati T, Valmary-Degano S, Boulinguez S, Launay F, Carle P, Lauwers F, Payoux P, Le Guellec S, Brousset P, Lamant L.

Hum Pathol. 2008 Aug;39(8):1136-42. doi: 10.1016/j.humpath.2007.12.006. Epub 2008 May 20.

PMID:
18495211

Supplemental Content

Support Center